Search our Database of Scientific Publications and Authors

I’m looking for a
    Endocrine disruptors and prostate cancer.
    Arch Esp Urol 2017 04;70(3):331-335
    Unidad docente de Urología. Departamento de Cirugía. Facultad de Medicina. Universidad de Málaga. Málaga.España.
    Objectives: Although prostate cancer is probably the most frequent cancer in men, little is known about its etiology. Clear evidence exists about variations in the incidence of prostate cancer between populations living in different countries. These variations could be explained by differences in lifestyle and a possible association with a set of substances that are able to intervene in the origin of the disease.

    Methods: The reason that lifestyle may be the cause of prostate cancer is related to endocrine disruptors. These are a group of chemical substances that can mimic or alter hormone signaling. These disruptors are able to exert their effect at very low doses and act insidiously over the years, even being able to pass their effect on from one generation to the next. Cholesterol is an essential precursor in the synthesis of androgens, estrogens and other substances that are active in prostate cancer. Cholesterol is a central metabolite in lipid metabolism, the inflammatory response and other elements involved in the formation and progression of cancer. High cholesterol concentrations can give rise to the accumulation of androgens in tumor cells. Additionally, endocrine disruptors have been identified as being responsible for processes related with fertility, genital malformations and various hormonedependent cancers. Disruptors already identified include diethylstilbestrol, dichlorodiphenyltrichloroethane (DDT), polychlorinated biphenyls and dioxins.

    Results: Though no clear direct association has yet been found in humans between most endocrine disruptors and prostate cancer, evidence suggests that an inadequate diet and contact with certain toxic agents predisposes to the disease. These disruptors are known to be especially relevant at particular times, such as during pregnancy, neonatal stages and puberty.

    Conclusions: The problem with these toxic agents is that their peculiarities and way of acting over time make their study difficult. Nonetheless, research must be encouraged given their importance.

    Similar Publications

    Endocrine disrupting compounds and prostate cancer.
    Cancer Lett 2006 Sep 17;241(1):1-12. Epub 2005 Nov 17.
    Department of Cell Biology, University of Cincinnati College of Medicine, P.O. Box 670521, 3125 Eden Ave., Cincinnati, OH 45267-0521, USA.
    Prostate cancer is a major health concern and is treated based on its hormone dependence. Agents that alter hormone action can have substantial biological effects on prostate cancer development and progression. As such, there is significant interest in uncovering the potential effects of endocrine disrupting compound (EDC) exposure on prostate cancer. Read More
    Endocrine disruptors and prostate cancer risk.
    Endocr Relat Cancer 2008 Sep 4;15(3):649-56. Epub 2008 Jun 4.
    Department of Urology, University of Illinois at Chicago, Chicago, Illinois 60612, USA.
    There is increasing evidence both from epidemiology studies and animal models that specific endocrine-disrupting compounds may influence the development or progression of prostate cancer. In large part, these effects appear to be linked to interference with estrogen signaling, either through interacting with ERs or by influencing steroid metabolism and altering estrogen levels within the body. In humans, epidemiologic evidence links specific pesticides, PCBs and inorganic arsenic exposures to elevated prostate cancer risk. Read More
    [Endocrine disruptors are a novel direction of endocrinologic scientific investigation].
    Vestn Ross Akad Med Nauk 2012 (3):56-61
    Endocrine disruptors are exogenous anthropogenic chemicals (pesticides, herbicides, polychlorinated biphenyls, bisphenol A, polybrominated diphenyl ethers, phthalates and others), that are able to bind hormonal receptors of endocrine and other cells in vivo and act like hormones. These substances disrupt endocrine regulation of metabolism, reproduction and adaptive reactions of organisms and promote human and animal endocrine disorders. Read More
    Phenotypic malignant changes and untargeted lipidomic analysis of long-term exposed prostate cancer cells to endocrine disruptors.
    Environ Res 2015 Jul 29;140:18-31. Epub 2015 Mar 29.
    Department of Environmental Chemistry, Institute of Environmental Assessment and Water Research (IDAEA-CSIC), c/ Jordi Girona 18-24, 08034 Barcelona, Spain. Electronic address:
    Endocrine disruptors (EDs) are a class of environmental toxic molecules able to interfere with the normal hormone metabolism. Numerous studies involve EDs exposure to initiation and development of cancers, including prostate cancer. In this work, three different EDs (aldrin, aroclor 1254 and chlorpyrifos (CPF)) were investigated as potential inducers of a malignant phenotype in DU145 prostate cancer cells after a chronic exposure. Read More